Enact Holdings, Inc. (ACT) SEC Filings

Enact Holdings, Inc. (ACT) had a Form 4 filed for executive vice president, general counsel and secretary Evan Stolove, reporting a sale of common stock. On 2026-08-17, Stolove sold 20,024 shares of Enact common stock in a sale classified as an open market or private transaction at a weighted average price of $49.524 per share, with individual trade prices ranging from $49.50 to $49.635 per share. After this transaction, Stolove directly held 32,003 shares of Enact common stock.

ACT filed a notice of proposed sale of common stock. The filing lists 20,024 shares of common stock to be sold through Fidelity Brokerage Services LLC on NASDAQ, with an approximate aggregate market value of $991,687.66, and notes 137,483,671 shares outstanding. The shares come from multiple restricted stock vesting compensation awards between September 2024 and March 2025.

Enact Holdings, Inc. reported strong profitability for the quarter ended June 30, 2026, with net income of 174,838 (thousand) versus 167,808 (thousand) a year earlier and diluted EPS of $1.25. Total revenues were 317,308 (thousand), as stable premiums combined with higher net investment income.

The loss ratio rose to 14% from 10% as favorable reserve releases were 37,966 (thousand), down from 46,353 (thousand), while current‑year mortgage delinquencies drove 66,528 (thousand) of losses incurred. New insurance written reached $15.2 billion, up 15%, and primary persistency was 80%.

Capital remains robust. Equity was 5,395,535 (thousand); EMICO’s risk‑to‑capital ratio was 9.9:1 and PMIERs available assets of 5,002 (million) exceeded net required assets of 3,108 (million) for a 161% sufficiency ratio. Year‑to‑date, Enact repurchased 4,479,192 shares for 186,536 (thousand) and paid common dividends of $0.45 per share.

Enact Holdings, Inc. reported second-quarter 2026 results with GAAP net income of $175 million, or $1.25 per diluted share, and adjusted operating income of $177 million, or $1.26 per diluted share. Annualized return on equity was 13.0% and adjusted operating ROE was 13.2%. Net premiums earned were $245 million, while net investment income increased to $73 million.

Mortgage insurance activity remained strong, with new insurance written of $15 billion, up 19% from 1Q26 and 15% from 2Q25, and primary insurance in-force of $274 billion, a 2% year-over-year increase. Losses incurred were $33 million, producing a 14% loss ratio, and the expense ratio was 21%. Capital strength and shareholder returns were emphasized through a $0.24 per-share quarterly dividend, about $93 million of share repurchases in the quarter, and PMIERs sufficiency of 161%, or approximately $1.9 billion above required assets. The company now expects total 2026 capital return of $550 million to $600 million.

Genworth Holdings, Inc., a major shareholder of Enact Holdings, Inc., reported selling 523,226 shares of Enact common stock on July 31, 2026. The sale was made to Enact pursuant to a Share Repurchase Agreement dated February 2, 2026, at a price of $45.9192 per share, determined as a weighted average under the agreement’s terms. Following this transaction, Genworth holds 111,078,346 Enact shares, representing approximately 81% of Enact’s outstanding common stock. The filing indicates the transaction was not executed under a Rule 10b5-1 trading plan.

Genworth Holdings, Inc., a major shareholder of Enact Holdings, Inc., reported selling 605,067 shares of Enact common stock on June 30, 2026. The shares were sold at a price of $42.277 per share pursuant to a Share Repurchase Agreement between Enact and Genworth dated February 2, 2026.

After this transaction, Genworth directly holds 111,601,572 Enact shares and owns approximately 81% of Enact’s outstanding common stock. The filing characterizes the transaction as a sale and notes that the repurchase price was determined under the agreement using a weighted average price Enact paid for purchases from third parties.

Enact Holdings EVP & Chief Operations Officer Brian Gould reported routine equity compensation activity involving restricted stock units (RSUs). On June 18, 2026, he received RSU grants of 23, 19, and 12 units, each settling into one share of Enact common stock on a 1:1 basis.

The footnotes state these additional RSUs were acquired under dividend reinvestment terms tied to a quarterly cash dividend of $0.24 per share paid on June 18, 2026. The RSUs vest and convert into common stock in three equal annual installments starting on February 16, 2025, February 21, 2026, and February 13, 2027, respectively, reflecting ongoing multi‑year equity incentives rather than open‑market trades.

Enact Holdings, Inc. director Michael A. Bless acquired 176 Deferred Stock Units as a grant under his director award arrangement. The units were credited at a price of $0.00 per unit through dividend reinvestment from a dividend paid at $0.24 per share. These Deferred Stock Units will be settled in shares of Common Stock one year after he ceases serving as a director. Following this award, his reported Deferred Stock Unit balance stands at 30,747.329 units held directly.

Enact Holdings, Inc. director Debra Still reported a routine compensation-related transaction involving deferred stock units. On June 18, 2026, she acquired 201 deferred stock units through dividend reinvestment at a dividend of $0.24 per share under a director award agreement. These deferred stock units will be paid out in shares of common stock one year after she terminates service as a director. Following this acquisition, her direct holdings in deferred stock units increased to 34,846.248 units.